Denosumab (Xgeva®)

Newfoundland & LabradorCommon name: Denosumab
Brand name: Xgeva®

What is Denosumab?

Denosumab is a monoclonal antibody that is used to treat osteoporosis in men diagnosed with prostate cancer. Denosumab works by stopping bone cells (osteoclasts) from breaking down bone structure.

How is Denosumab administered?

Denosumab is administered by subcutaneous injection (under the skin).

What are possible side effects of this treatment?

Everyone responds differently to treatments for bone metastases – some experience many side effects while others experience very few. Below are some side effects experienced by those who received denosumab. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Diarrhea
  • Fatigue
  • Nausea
  • Rash
  • Skin changes
  • Weakness

Is Denosumab covered in my province or territory?

Denosumab is covered by provincial drug programs in:
  • British Columbia
  • Manitoba
  • New Brunswick
  • Nova Scotia
  • Ontario
  • Quebec
  • Saskatchewan
Denosumab is not covered by provincial drug programs in:
  • Alberta
  • Newfoundland & Labrador
  • Northwest Territories
  • Prince Edward Island
  • Yukon
​Unknown if denosumab is covered by provincial drug programs in:
  • ​Nunavut

VICTORY Program – Supportive Care (XGEVA)
Patient Assistance Programs are offered by pharmaceutical companies to provide medications and/or financial assistance to those who cannot afford to pay for their medicine.

Please call 1-888-706-4717 for more information and to see if you qualify for this program.

Last Reviewed: July 2017

Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive